SAN FRANCISCO Feb. 29 2012 PRNewswire &160; Nektar Therapeutics Nasdaq NKTR today announced that it agreed to sell to Royalty Pharma its royalties on future sales of CIMZIA&174; under Nektar's agreement with UCB Pharma and MIRCERA&174; under...
↧